Stockchase Opinions

Jim Cramer - Mad MoneyincyteINCYBUYSep 22, 2025

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

$84.73

Stock price when the opinion was issued

$117.72

As of Jul 24, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.